Stockreport

Zevra jumps 19% after Q4 EPS tops consensus estimates [Seeking Alpha]

Zevra Therapeutics, Inc.  (ZVRA) 
PDF The revenue came in at $34.1M, rising about 184% Y/Y and 31% Q/Q. This was mainly driven by strong ZVRA's Earnings Call Insights: Here's what you need to know Quick [Read more]